Possible underlying mechanisms might involve the role of TMAO-producing enzyme (i.e., flavin-containing monooxygenase-3 (FMO3)) in regulating obesity and beiging of white adipose tissue [12], as well as increased hepatic insulin resistance correlate with elevated TMAO concentration [13]. The gene discussed is FMO3; the disease is obesity disorder.